Search

Your search keyword '"Stock options"' showing total 3,630 results
Start Over Descriptor "Stock options" Topic compensation management
3,630 results on '"Stock options"'

1. Elicio Therapeutics reports inducement grants

Subjects
Stock options, Compensation management, Business, News, opinion and commentary
Abstract

Elicio Therapeutics announced that on September 16, 2024, Elicio granted an aggregate of 4,800 inducement stock options to a new employee, as an inducement material to the individual entering into [...]

Published
2024

2. EyePoint reports inducement grants under NASDAQ listing rule

Subjects
Stock options, Compensation management, Business, News, opinion and commentary
Abstract

EyePoint Pharmaceuticals announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). [...]

Published
2024

3. Viridian Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, Arts and entertainment industries
Abstract

Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, reported that a majority of the independent directors serving on [...]

Published
2024

4. Aligos Therapeutics announces inducement grants under Nasdaq listing rule

Subjects
Stock options, Compensation management, Business, News, opinion and commentary
Abstract

Aligos Therapeutics announced that the Compensation Committee of the Company's Board of Directors granted a non-qualified stock option to purchase an aggregate of 3,500 shares of the Company's stock to [...]

Published
2024

5. Taysha Gene Therapies announces inducement grant under Nasdaq listing rule

Subjects
Stock options, Gene therapy, Compensation management, Business, News, opinion and commentary
Abstract

Taysha Gene Therapies announced that, on September 3, 2024, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 311,000 shares of the Company's [...]

Published
2024

6. Adverum Biotechnologies reports inducement grants under Nasdaq listing rule

Subjects
Stock options, Biotechnology, Biotechnology industry, Compensation management, Business, News, opinion and commentary
Abstract

Adverum Biotechnologies announced that on September 3, 2024, the Compensation Committee of Adverum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 12,660 shares of common [...]

Published
2024

7. Vaxart reports inducement grants under Nasdaq listing rule

Subjects
Stock options, Compensation management, Business, News, opinion and commentary
Abstract

Vaxart announced that on August 26, 2024, the Compensation Committee of the Board of Directors granted inducement equity awards covering an aggregate of 32,250 shares of its common stock to [...]

Published
2024

10. Restaurant Brands sees FY24 capital expenditures $300M

Subjects
Stock options, Restaurants -- Investments, Compensation management, Company investment, Business, News, opinion and commentary
Abstract

The company said, 'RBI continues to expect consolidated capital expenditures, tenant inducements and incentives (excluding RH) of approximately $300 million. RBI now expects Adjusted Net Interest Expense, between $565 million [...]

Published
2024

11. Theravance Biopharma reaffirms FY24 R&D expenses view $30M-$36M

Subjects
Innoviva Inc., Biological products industry, Stock options, Biotechnology industry, Compensation management, Business, News, opinion and commentary
Abstract

The Company continues to expect FY24 R&D expenses of $30M-$36M and SG&A expenses of $45M-$55M, in each case excluding share-based compensation. The Company continues to expect full year share-based compensation [...]

Published
2024

12. BioCryst reports inducement grants under Nasdaq listing rule

Subjects
BioCryst Pharmaceuticals Inc. -- Officials and employees, Stock options, Compensation management, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

BioCryst Pharmaceuticals announced that the compensation committee of BioCryst's board of directors granted nine newly-hired employees stock options to purchase an aggregate of 40,350 shares, and restricted stock units covering [...]

Published
2024

13. Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, Arts and entertainment industries
Abstract

Incyte reported that it granted restricted stock unit awards (RSUs) representing an aggregate of 14,577 shares of the Company's common stock and stock option awards to purchase an aggregate of [...]

Published
2024

14. Anika Therapeutics reports inducement grants under Nasdaq listing rule

Subjects
Anika Therapeutics Inc. -- Officials and employees, Stock options, Compensation management, Business, News, opinion and commentary
Abstract

Anika Therapeutics announced that on July 1, 2024, Anika granted non-statutory stock options covering an aggregate of 2,500 shares of common stock at a per share exercise price of $25.85, [...]

Published
2024

15. Gritstone announces inducement grants under Nasdaq listing rule

Subjects
Stock options, Compensation management, Business, News, opinion and commentary
Abstract

Gritstone bio announced that the Compensation Committee of the company's Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 39,000 shares of its common stock [...]

Published
2024

16. Kura Oncology reports inducement grants under Nasdaq listing rule

Subjects
Stock options, Compensation management, Business, News, opinion and commentary
Abstract

Kura Oncology granted inducement awards consisting of nonstatutory stock options to purchase 128,700 shares of common stock to eight new employees under the Company's 2023 Inducement Option Plan. The Compensation [...]

Published
2024

17. Theravance Biopharma sees FY24 R&D expenses $30M-$36M

Subjects
Innoviva Inc., Biological products industry, Stock options, Biotechnology industry, Compensation management, Business, News, opinion and commentary
Abstract

Sees FY24 SG&A expenses of $45M-$55M in each case excluding share-based compensation. Sees FY24 share-based compensation expenses $18M-$22M. Expects Non-GAAP net loss in the first half of 2024 and to [...]

Published
2024

18. Zentalis Pharmaceuticals Updates on Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, Arts and entertainment industries
Abstract

Zentalis Pharmaceuticals, a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, reported that on May 1, the Compensation Committee of Zentalis' [...]

Published
2024

19. Inozyme reports inducement grants under Nasdaq listing rule

Subjects
Stock options, Compensation management, Business, News, opinion and commentary
Abstract

Inozyme Pharma announced that it granted stock options to one new employee to purchase shares of the Company's common stock, pursuant to the Company's 2023 Inducement Stock Incentive Plan, as [...]

Published
2024

20. Acadia Pharmaceuticals Updates on Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Acadia Pharmaceuticals Inc., Stock options, Compensation management, Arts and entertainment industries
Abstract

Acadia Pharmaceuticals Inc. reported that on April 10, the Compensation Committee of Acadias Board of Directors (the Committee) granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares [...]

Published
2024

22. Ocular Therapeutix reports inducement grants under Nasdaq listing rule

Subjects
Stock options, Compensation management, Business, News, opinion and commentary
Abstract

Ocular Therapeutix has granted inducement equity awards to its newly appointed Senior Vice President, Global Head of Biometrics, Liansheng Zhu. The awards were approved by the Compensation Committee of Ocular [...]

Published
2024

23. Ideaya Biosciences announces inducement grants under Nasdaq listing rule

Subjects
Stock options, Compensation management, Business, News, opinion and commentary
Abstract

IDEAYA Biosciences announced that, on March 28, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 70,000 shares of the Company's [...]

Published
2024

25. Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, General interest, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO: Aligos Therapeutics has issued the following news release: Aligos Therapeutics, Inc. (Nasdaq: ALGS, 'Aligos', 'Company'), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class [...]

Published
2024

27. PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
PTC Therapeutics Inc., Stock options, Compensation management, Pharmaceutical industry, Business, News, opinion and commentary
Abstract

WARREN, N.J., Sept. 12, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept. 8, 2024, the company approved non-statutory stock options to purchase an aggregate of [...]

Published
2024

28. Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, Business, Business, international
Abstract

FOSTER CITY, Calif. -- Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that on September 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified [...]

Published
2024

29. Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Subjects
Bupivacaine, Stock options, Biotechnology industry, Compensation management, Banking, finance and accounting industries, Business, Zilretta (Medication), Exparel (Medication)
Abstract

TAMPA, Fla., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced the [...]

Published
2024

30. Codexis Announces New Employment Inducement Grants

Subjects
Codexis Inc. -- Officials and employees, Biological products industry -- Officials and employees, Stock options, Compensation management, Banking, finance and accounting industries, Business
Abstract

REDWOOD CITY, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as [...]

Published
2024

31. Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Subjects
Stock options, Nervous system diseases, Compensation management, Business, Business, international
Abstract

LA JOLLA, Calif. -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the grant of inducement awards to [...]

Published
2024

32. Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Genes, Gene therapy, Compensation management, Banking, finance and accounting industries, Business
Abstract

DALLAS, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of [...]

Published
2024

33. Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, Business, Business, international
Abstract

WALTHAM, Mass. -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the 'company' or 'Viridian'), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced [...]

Published
2024

34. Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Biotechnology, Biotechnology industry, Compensation management, Banking, finance and accounting industries, Business
Abstract

REDWOOD CITY, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on September 3, 2024, the Compensation Committee of Adverum's Board of Directors granted [...]

Published
2024

35. Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Chimerix Inc., Stock options, Compensation management, General interest, News, opinion and commentary
Abstract

DURHAM, N.C: Chimerix, Inc. has issued the following news release: Chimerix (NASDAQ:CMRX), today announced that on August 20, 2024, the Compensation Committee of Chimerix's Board of Directors granted an inducement [...]

Published
2024

36. Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, General interest, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO, Calif: Vaxart, Inc has issued the following news release: Vaxart, Inc. (Nasdaq: VXRT) (the 'Company' or 'Vaxart') today announced that on August 26, 2024, the Compensation Committee [...]

Published
2024

37. Voyager Therapeutics Announced Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Stock markets, Labor contracts, Compensation management, Stock market, General interest, News, opinion and commentary
Abstract

LEXINGTON: Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agreement with a newly hired employee that, among other things, provides [...]

Published
2024

38. Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, Banking, finance and accounting industries, Business
Abstract

DURHAM, N.C., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on August 20, 2024, the Compensation Committee of Chimerix's Board of Directors granted an inducement award to [...]

Published
2024

40. Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, Banking, finance and accounting industries, Business
Abstract

SOUTH SAN FRANCISCO, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the 'Company' or 'Vaxart') today announced that on August 26, 2024, the Compensation Committee of the [...]

Published
2024

41. Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Stock markets, Labor contracts, Compensation management, Stock market, Banking, finance and accounting industries, Business
Abstract

LEXINGTON, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agreement with a newly [...]

Published
2024

42. IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c) (4)

Subjects
Stock options, Compensation management, General interest, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO: IDEAYA Biosciences, Inc. has issued the following news release: IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted [...]

Published
2024

43. Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, Banking, finance and accounting industries, Business
Abstract

BRISBANE, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class[sup.1] targeted and immune-mediated therapeutics to fight cancer, today announced that the [...]

Published
2024

44. TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Subjects
Transplantation of organs, tissues, etc., High technology industry, Stock options, Compensation management, Liver diseases -- Care and treatment, Business, News, opinion and commentary
Abstract

ANDOVER, Mass., Aug. 20, 2024 /PRNewswire/ -- TransMedics Group, Inc. ('TransMedics') (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and [...]

Published
2024

45. Anika Reported Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Anika Therapeutics Inc. -- Officials and employees, Stock options, Medical test kit industry -- Officials and employees, Medical equipment and supplies industry -- Officials and employees, Compensation management, General interest, News, opinion and commentary
Abstract

BEDFORD: Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1, 2024, Anika granted non-statutory stock options (Options) covering an [...]

Published
2024

46. EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Subjects
United States. Food and Drug Administration, Stock options, Compensation management, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the [...]

Published
2024

47. Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Anika Therapeutics Inc. -- Officials and employees, Stock options, Medical test kit industry -- Officials and employees, Medical equipment and supplies industry -- Officials and employees, Compensation management, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1, 2024, Anika granted non-statutory stock options (Options) covering [...]

Published
2024

48. 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, General interest, News, opinion and commentary
Abstract

SAN FRANCISCO: 89bio, Inc. has issued the following news release: 89bio, Inc. (the 'Company' or '89bio') (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative [...]

Published
2024

49. 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Subjects
Stock options, Compensation management, Banking, finance and accounting industries, Business
Abstract

SAN FRANCISCO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the 'Company' or '89bio') (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for [...]

Published
2024

50. bluebird bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Subjects
bluebird bio, Inc., Stock options, Biotechnology industry, Compensation management, General interest, News, opinion and commentary
Abstract

SOMERVILLE: bluebird bio, Inc. has issued the following news release: bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Compensation Committee of the Company's Board of Directors approved an inducement [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results